Consensus recommendations

Consensus recommendations

Grade

All individuals with cirrhosis should be enrolled in HCC screening programs.

A1

All individuals with cirrhosis should be offered DAA treatment for HCV infection.

A1

People with cirrhosis and prior HCC should be closely monitored for HCC recurrence during and after DAA therapy for HCV infection.

B2

HCC screening for all individuals with no cirrhosis is not cost-effective.

A1